semaglutide ckd trial Semaglutides Are Poised to Remake Chronic Kidney Disease Care Media Centre | EASD

Current evidence suggests sequential or alternative approaches may be safer

A once-a-week Semaglutide prescription injection designed to help you lose an average of 16.5% of your body weight* by making you feel full faster and longer.

A recent study found that GLP-1 medications like Ozempic and Wegovy may help improve breast cancer survival rates among women with obesity and type 2 diabetes.

Those switched to placebo then regained 14.0% over the next 52 weeks, while those who continued tirzepatide lost an additional 5.5%

The data bases Pubmed, Lilacs, Scielo, Scopus, Web of Science and Cochrane Library were surveyed